This inventor holds 2 USPTO granted patents. Top assignee: Cornell University. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Daniel M. Knowles
Introduction
Daniel M. Knowles is an accomplished inventor based in Forest Hills, NY (US). He has made significant contributions to the field of molecular biology, particularly in relation to Kaposi's sarcoma-associated herpesvirus (KSHV). With a total of 2 patents, his work has implications for both research and therapeutic applications.
Latest Patents
Knowles' latest patents focus on the encoding of proteins associated with KSHV. The first patent involves isolated nucleic acid molecules that encode various proteins, including an antigenic receptor protein, a G protein coupled receptor, and a cyclin protein. This invention also provides expression vectors and host cells that incorporate these nucleic acid molecules. Additionally, methods for modulating the expression of KSHV proteins in host cells are included. The second patent introduces KSHV positive cell lines, specifically designed for the propagation of KSHV. These cell lines, designated BC-2 and BC-3, are particularly valuable for research purposes, as they allow for the study of KSHV in a controlled environment.
Career Highlights
Daniel M. Knowles is affiliated with Cornell University, where he continues to advance research in virology and molecular biology. His work has garnered attention for its potential to enhance understanding of KSHV and its associated diseases.
Collaborations
Knowles has collaborated with notable researchers in his field, including Ethel Cesarman and Enrique Mesri. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Daniel M. Knowles exemplifies the innovative spirit of modern science through his work on KSHV. His patents and research contributions are paving the way for advancements in understanding and treating viral infections.